ASNC recently joined a coalition of 6 medical societies asking the Department of Commerce and the Trump Administration to exclude or defer tariffs on radiopharmaceuticals and medical isotopes until adequate domestic supplies are established.
In their letter to U.S. Secretary of Commerce Howard Lutnick, ASNC and the American Association of Physicists in Medicine, American College of Cardiology (ACC), American College of Radiology, American Society for Radiation Oncology, and Society of Nuclear Medicine and Molecular Imaging, urged the Administration to continue collaborating with stakeholders on efforts to strengthen domestic production capacity and to develop a national strategy for radiopharmaceutical supply chain security that includes contingency planning for future disruptions.
The coalition reiterated comments submitted by ASNC and the ACC in May, shortly after the Commerce Department requested input on its section 232 investigation aimed at determining the effects on national security of importing pharmaceuticals and pharmaceutical ingredients.
Related Posts
New Webinar Will Explain Reimbursement Changes in Medicare’s 2026 Final Rules
Both the Medicare Physician Fee Schedule and the Hospital Outpatient Prospective Payment…
Medical Societies Renew Push for Prior Authorization Legislation
ASNC has joined more than 125 medical societies on a letter to…
ASNC Releases Payment Charts Compiling Final 2026 Rates for All Nuclear Cardiology Billing Codes
Access to the latest MPFS and HOPPS Payment Charts is available as…

